Overview

Evaluation of the Efficacy of Intramuscular Islet Autograft After Extensive Pancreatectomy

Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
The liver may not be an optimal site for islet transplantation due to obstacles by an instant blood-mediated inflammatory response, and low revascularization of transplanted islets. Therefore, intramuscular islet transplantation offers an attractive alternative, based on its simplicity, enabling easier access for noninvasive graft imaging and cell explantation.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University Hospital, Lille